Your Trusted Brand for Over 35 Years

Life Extension Magazine

<< Back to July 2009

July 2009

By William Faloon

Nancy-Ann DeParle
Director
Office of Health Reform
The White House
1600 Pennsylvania Avenue NW
Washington, DC 20500

Dear Ms. DeParle,

The FDA is denying Americans access to a low-cost dietary supplement (pyridoxamine) in order to make this natural vitamin an expensive prescription drug.

If the FDA succeeds, the American public’s health will be severely injured, and Medicare will be forced to fork over millions of unnecessary dollars to subsidize pyridoxamine as an overpriced pharmaceutical.

Safety is not the issue. The FDA admits its plan to ban pyridoxamine is in direct response to a petition filed by a pharmaceutical company. This company wants the FDA to grant it exclusive status to sell the safest form of vitamin B6 (pyridoxamine) as a drug!

At stake are the lives of millions of Americans whose health can be protected against a host of age-related diseases if pyridoxamine can be freely added to dietary supplement formulas.

The FDA has received a petition from another pharmaceutical company seeking to ban the sale of pyridoxal-5’-phosphate, which is another form of vitamin B6 that has been safely sold as a dietary supplement for decades. I ask that you instruct the FDA to reject this petition since pyridoxal-5’-phosphate provides numerous health benefits that cannot be obtained with conventional vitamin B6 (pyridoxine HCl) supplements.

I also ask that you mandate the FDA to reverse its inappropriate ban against pyridoxamine, so that it can once again be freely sold as a vitamin B6 dietary supplement.

Your administration has prioritized the need to make healthcare affordable to all.

One simple way of accomplishing this is to not allow pharmaceutical companies to enjoy bureaucracy-bestowed monopolies courtesy of biased FDA officials.

To review the complete facts about the pyridoxamine/pyridoxal-5’-phosphate controversy, log on to www.lef.org/pyridoxamine

Sincerely,

Name:

Address: